The Metabotropic Glutamate Receptor System: G-Protein Mediated Pathways that Modulate Neuronal and Vascular Cellular Injury
Journal:
Current Medicinal Chemistry - Central Nervous System Agents
Volume:
2
Page:
17-28
Author(s):
Shi-Hua Lin, Zhao Zhong Chong and Kenneth Maiese
Nitric Oxide Therapies in Vascular Diseases
Journal:
Current Pharmaceutical Design
Volume:
8
Page:
155-166
Author(s):
E. M. Kurowska
Mesoionic Oxatriazoles (MOTA): NO-Donating Characteristics and Pharmacology
Journal:
Current Pharmaceutical Design
Volume:
8
Page:
167-176
Author(s):
R. J. Gryglewski, E. Marcinkiewicz, J. Robak, Z. Michalska and J. Madej
Nitric Oxide Related Therapeutic Phenomenon: A Challenging Task
Journal:
Current Pharmaceutical Design
Volume:
8
Page:
233-239
Author(s):
Giuseppe Cirino, Vincenzo Santagada and Giuseppe Caliendo
Interaction of Cyclosporine A and the Renin-Angiotensin System New Perspectives
Journal:
Current Drug Metabolism
Volume:
3
Page:
61-71
Author(s):
M. Lassila
Genetic Engineering in Allotransplantation of Vascularized Organs
Journal:
Current Gene Therapy
Volume:
2
Page:
9-21
Author(s):
P. Mathieu, C. Chauveau, D. Bouchet, C. Guillot, L. Tesson and I. Anegon
Alzheimers Disease: Targets For Drug Development
Journal:
Mini-Reviews in Medicinal Chemistry
Volume:
2
Page:
1-9
Author(s):
Andrew J. Larner
Subject Index To Volume 7
Journal:
Current Pharmaceutical Design
Volume:
8
Page:
85-97
Author(s):
Science Publishers Bentham
Thrombin Activable Fibrinolysis Inhibitor (TAFI): Molecular Genetics of an Emerging Potential Risk Factor for Thrombotic Disorders
Journal:
Current Drug Targets - Cardiovascular & Hematological Disorders
Volume:
1
Page:
59-74
Author(s):
M. B. Boffa, M. E. Nesheim and M. L. Koschinsky
Angiogenesis and Angiogenesis Inhibitors: a New Potential Anticancer Therapeutic Strategy
Journal:
Current Drug Targets - Immune, Endocrine & Metabolic Disorders
Volume:
1
Page:
241-253
Author(s):
G. Ranieri and G. Gasparini